Breaking News Instant updates and real-time market news.

KDMN

Kadmon

$2.68

-0.04 (-1.47%)

08:08
11/06/18
11/06
08:08
11/06/18
08:08

Kadmon: KD033 inhibited tumor growth in models in study

Kadmon Holdings announced it will present preclinical data on KD033, its anti-PD-L1/IL-15 fusion protein in development for oncology indications, at the Society for Immunotherapy of Cancer Annual Meeting, taking place November 7-11, 2018, in Washington, D.C. KD033 is a novel immunotherapy designed to stimulate an immune response directed to the tumor microenvironment. Recombinant IL-15 alone, which stimulates cancer-fighting immune effector cells, is not well tolerated when administered systemically. Kadmon has developed a novel approach to overcome this challenge by fusing IL-15 to an anti-PD-L1 antibody to direct IL-15 activity specifically to the tumor microenvironment, promoting efficacy and inducing durable responses while potentially increasing tolerability. New data demonstrated that a single dose of KD033 inhibited tumor growth across multiple in vivo syngeneic tumor models and achieved dose-dependent efficacy in a resistant melanoma syngeneic mouse model. KD033 induced a strong immune memory response with a single treatment, resulting in mice that remained tumor-free following several tumor re-challenges. Furthermore, KD033 in combination with anti-PD1 therapy demonstrated synergistic activity, providing rationale for administering KD033 in combination with other immune checkpoint inhibitors. "Although immunotherapy has been game-changing for the treatment of cancer, many tumors learn to evade current therapies, limiting efficacy and durability of response. New approaches are needed to address relapsed or refractory patients as well as non-responders," said Harlan W. Waksal, M.D., President and CEO at Kadmon. "By directing a potent cancer-fighting response to the tumor site, KD033 has potential to safely overcome resistance and induce long-lasting responses for patients. We look forward to continuing our research on KD033 and initiating our first-in-patient studies in the second half of 2019."

  • 01

    Dec

KDMN Kadmon
$2.68

-0.04 (-1.47%)

12/21/17
JEFF
12/21/17
NO CHANGE
Target $9
JEFF
Buy
Kadmon Q1 data could bring 'significant' upside, says Jefferies
Jefferies analyst Biren Amin believes Kadmon's Phase II data for KD025 in chronic graft-versus-host disease, expected in Q1 of 2018, represent "significant" upside with little downside risk. KD025 has shown "encouraging activity" in a difficult to treat population, Amin tells investors in a research note. He assumes U.S. market entry of KD025 for treatment of chronic graft-versus-host disease in 2020 and estimates U.S. peak sales of 333.1M. The analyst has a Buy rating on Kadmon shares with a $9 price target.
02/13/18
JEFF
02/13/18
NO CHANGE
Target $16
JEFF
Buy
Kadmon price target raised to $16 from $9 at Jefferies
Jefferies analyst Biren Amin raised his price target for Kadmon Holdings to $16 after the company announced positive data on its Phase II trial of KD025 in idiopathic pulmonary fibrosis. The absolute improvement of 127 mL between arms surpasses the bar of 45-85 mL seen with existing therapies and the shares should react positively, Amin tells investors in a research note. He keeps a Buy rating on Kadmon shares.
02/13/18
PIPR
02/13/18
NO CHANGE
Target $9
PIPR
Overweight
Kadmon price target raised to $9 after data on KD025 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff noted that Kadmon announced "positive" topline Phase 2 data on KD025 in 29 evaluable idiopathic pulmonary fibrosis, or IPF, patients. Upon adding value for KD025 in IPF, the analyst increased his price target on Kadmon shares to $9 from $7 and reiterated his Overweight rating on the stock.
10/17/18
WBBS
10/17/18
UPGRADE
WBBS
Hold
Kadmon upgraded to Hold from Sell at WBB Securities

TODAY'S FREE FLY STORIES

DDAIF

Daimler AG

$0.00

(0.00%)

05:51
11/14/18
11/14
05:51
11/14/18
05:51
Hot Stocks
Daimler to open new R&D center in China to accelerate localization »

Daimler announced plans…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTI

British American Tobacco

$37.04

-1.04 (-2.73%)

, MO

Altria Group

$60.01

-1.18 (-1.93%)

05:46
11/14/18
11/14
05:46
11/14/18
05:46
Hot Stocks
Juul to halt social media promotions, stop selling most flavors in stores »

Juul Labs said in a…

BTI

British American Tobacco

$37.04

-1.04 (-2.73%)

MO

Altria Group

$60.01

-1.18 (-1.93%)

PM

Philip Morris

$86.42

-1.48 (-1.68%)

FB

Facebook

$142.19

0.67 (0.47%)

SNAP

Snap

$6.72

0.06 (0.90%)

TWTR

Twitter

$32.49

0.49 (1.53%)

GOOG

Alphabet

$1,036.33

-2.89 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 26

    Nov

  • 28

    Nov

  • 03

    Mar

AIBRF

AIB Group

$0.00

(0.00%)

05:44
11/14/18
11/14
05:44
11/14/18
05:44
Upgrade
AIB Group rating change  »

AIB Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$192.23

-1.925 (-0.99%)

, LITE

Lumentum

$38.95

1.445 (3.85%)

05:42
11/14/18
11/14
05:42
11/14/18
05:42
Recommendations
Apple, Lumentum, Qorvo analyst commentary  »

UBS drops Apple price…

AAPL

Apple

$192.23

-1.925 (-0.99%)

LITE

Lumentum

$38.95

1.445 (3.85%)

QRVO

Qorvo

$63.68

-0.12 (-0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

AMZN

Amazon.com

$1,631.68

-5.02 (-0.31%)

05:38
11/14/18
11/14
05:38
11/14/18
05:38
Periodicals
Amazon decided to split HQ2 in two in September, WSJ reports »

Amazon officials made the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Nov

  • 04

    Dec

RMED

Ra Medical Systems

$8.16

-0.455 (-5.28%)

05:33
11/14/18
11/14
05:33
11/14/18
05:33
Recommendations
Ra Medical Systems analyst commentary  »

Piper recommends purchase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

REGN

Regeneron

$342.12

-4.45 (-1.28%)

05:30
11/14/18
11/14
05:30
11/14/18
05:30
Recommendations
Regeneron analyst commentary  »

Regeneron survey…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 27

    Nov

  • 11

    Mar

  • 28

    Apr

  • 13

    May

PAAS

Pan American Silver

$14.13

-0.14 (-0.98%)

, TAHO

Tahoe Resources

$2.20

-0.055 (-2.44%)

05:28
11/14/18
11/14
05:28
11/14/18
05:28
Hot Stocks
Pan American Silver to acquire Tahoe Resources for $3.40 per share »

Pan American Silver…

PAAS

Pan American Silver

$14.13

-0.14 (-0.98%)

TAHO

Tahoe Resources

$2.20

-0.055 (-2.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$36.88

0.46 (1.26%)

05:20
11/14/18
11/14
05:20
11/14/18
05:20
Earnings
Breaking Earnings news story on Biohaven Pharmaceutical »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 27

    Nov

BRKR

Bruker

$32.65

-0.21 (-0.64%)

05:19
11/14/18
11/14
05:19
11/14/18
05:19
Hot Stocks
Bruker agrees to acquire Alicona Imaging GmbH, terms not disclosed »

Bruker Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESLT

Elbit Systems

$120.29

-1.45 (-1.19%)

05:18
11/14/18
11/14
05:18
11/14/18
05:18
Hot Stocks
Elbit Systems awarded $167M contract from Asia-Pacific country »

Elbit Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

FTI

TechnipFMC

$23.53

-1.24 (-5.01%)

, CVX

Chevron

$115.35

-2.12 (-1.80%)

05:16
11/14/18
11/14
05:16
11/14/18
05:16
Hot Stocks
TechnipFMC signs surface technologies frame agreement with Chevron »

TechnipFMC (FTI) has…

FTI

TechnipFMC

$23.53

-1.24 (-5.01%)

CVX

Chevron

$115.35

-2.12 (-1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

05:15
11/14/18
11/14
05:15
11/14/18
05:15
General news
Oil prices erased losses »

Oil prices erased losses…

SERV

ServiceMaster

$43.03

0.545 (1.28%)

05:14
11/14/18
11/14
05:14
11/14/18
05:14
Initiation
ServiceMaster initiated  »

ServiceMaster initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPGI

S&P Global

$180.07

-2.08 (-1.14%)

05:13
11/14/18
11/14
05:13
11/14/18
05:13
Initiation
S&P Global initiated  »

S&P Global initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 03

    Dec

RENN

Renren

$1.53

0.08 (5.52%)

05:13
11/14/18
11/14
05:13
11/14/18
05:13
Hot Stocks
Renren sells SNS business to Beijing Infinities Interactive Media »

Beijing Infinities…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCO

Moody's

$148.05

-2.03 (-1.35%)

05:12
11/14/18
11/14
05:12
11/14/18
05:12
Initiation
Moody's initiated  »

Moody's initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

K

Kellogg

$63.48

-0.81 (-1.26%)

05:08
11/14/18
11/14
05:08
11/14/18
05:08
Downgrade
Kellogg rating change  »

Kellogg downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

WYGPY

WorleyParsons

$0.00

(0.00%)

05:05
11/14/18
11/14
05:05
11/14/18
05:05
Upgrade
WorleyParsons rating change  »

WorleyParsons upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SURRY

Sun Art Retail Group

$0.00

(0.00%)

05:02
11/14/18
11/14
05:02
11/14/18
05:02
Downgrade
Sun Art Retail Group rating change  »

Sun Art Retail Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTT

CatchMark Timber

$9.14

0.045 (0.49%)

04:59
11/14/18
11/14
04:59
11/14/18
04:59
Recommendations
CatchMark Timber analyst commentary  »

CatchMark Timber price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLXN

Flexion

$16.40

0.17 (1.05%)

04:55
11/14/18
11/14
04:55
11/14/18
04:55
Conference/Events
Flexion management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

04:55
11/14/18
11/14
04:55
11/14/18
04:55
General news
Breaking General news story  »

Federal Reserve Chairman…

CRL

Charles River

$131.47

-2.125 (-1.59%)

, CRVS

Corvus Pharmaceuticals

$7.24

-0.28 (-3.72%)

04:55
11/14/18
11/14
04:55
11/14/18
04:55
Conference/Events
European Organization for Research & Treatment of Cancer to hold symposium »

The European Organization…

CRL

Charles River

$131.47

-2.125 (-1.59%)

CRVS

Corvus Pharmaceuticals

$7.24

-0.28 (-3.72%)

XCUR

Exicure

$0.00

(0.00%)

ZYME

Zymeworks

$13.04

-0.2 (-1.51%)

ARWR

Arrowhead

$12.48

-0.35 (-2.73%)

ALRN

Aileron Therapeutics

$2.21

0.33 (17.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 27

    Nov

BBT

BB&T

$51.07

0.53 (1.05%)

04:55
11/14/18
11/14
04:55
11/14/18
04:55
Conference/Events
BB&T to hold investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 18

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.